PALO ALTO, USA & MULGRAVE, Australia, Feb. 20, 2026 — Gyder Surgical announced the first commercial surgical cases in the United States using the GYDER® Hip Navigation System, performed by Paul M. Lombardi, M.D., at the **Tri-County Orthopedics’ Joint Replacement Institute outpatient center in New Jersey. The milestone marks the U.S. clinical rollout of the world’s first commercially available pin-less and image-less computer-assisted navigation system for Total Hip Arthroplasty (THA) using the anterior approach, designed to deliver real-time intraoperative guidance without CT scans, X-ray imaging, or invasive metallic pins.
Science Significance
The GYDER® Hip Navigation System introduces a novel advancement in orthopedic surgical navigation technology, utilizing patented algorithms to guide accurate acetabular cup placement during hip replacement procedures. Unlike conventional systems that rely on pelvic pins or preoperative imaging, the GYDER® platform provides real-time intraoperative alignment data without radiation exposure or invasive hardware fixation. This approach minimizes complications associated with traditional navigation systems, including pelvic pain, fracture risk, bursitis, and retained metallic fragments. By eliminating dependency on CT or fluoroscopy, the system reduces radiation burden while maintaining high precision. Enhanced cup positioning accuracy has been associated with improved implant longevity, reduced dislocation rates, and optimized biomechanical alignment, supporting better long-term clinical outcomes in total hip arthroplasty.
Regulatory Significance
The GYDER® Hip System has received U.S. FDA 510(k) clearance, confirming substantial equivalence to predicate orthopedic navigation devices while validating safety and performance standards under U.S. medical device regulations. The commercial launch in the United States follows prior regulatory clearance and successful utilization in Australia and India, reinforcing global compliance and market readiness. Device validation under 510(k) pathways requires rigorous evaluation of clinical performance, risk management, and manufacturing controls consistent with Quality System Regulation (QSR) requirements. The rollout demonstrates alignment with regulatory frameworks governing surgical navigation systems, including cybersecurity, software validation, and usability testing standards applicable to image-less guidance technologies.
Business Significance
Advertisement
The commercial introduction positions Gyder Surgical within the rapidly expanding outpatient orthopedic surgery and ambulatory surgery center (ASC) market. As hip replacement procedures increasingly transition to outpatient settings, technologies that reduce operative time, streamline workflows, and eliminate imaging infrastructure demands offer strong competitive advantages. The GYDER® system’s quick calibration and minimal workflow disruption make it well-suited for high-throughput surgical centers. With U.S. outpatient joint replacement volumes rising significantly over the past decade, scalable navigation solutions represent a growing segment within the orthopedic MedTech landscape. The milestone signals Gyder Surgical’s entry into a high-growth U.S. market, supporting revenue expansion and technology adoption among leading orthopedic surgeons.
Patients’ Significance
For patients undergoing total hip arthroplasty, the introduction of pin-less and image-less navigation offers meaningful clinical benefits. Avoiding pelvic pins reduces procedural invasiveness and potential postoperative discomfort, while eliminating reliance on CT or fluoroscopy reduces radiation exposure. Improved acetabular cup placement accuracy may decrease the likelihood of revision surgery, implant instability, and long-term complications. In outpatient environments, streamlined navigation contributes to efficient recovery pathways and optimized surgical outcomes. The integration of advanced guidance tools in ambulatory centers supports broader patient access to precise, minimally disruptive joint replacement procedures.
Policy Significance
The launch aligns with broader healthcare policy trends encouraging value-based surgical innovation and outpatient care expansion. Policymakers and payers increasingly prioritize technologies that enhance precision while reducing complications and downstream healthcare costs. Navigation systems that improve implant positioning and reduce revision rates can contribute to long-term cost containment strategies. Additionally, image-less systems support efforts to limit radiation exposure in clinical practice. As healthcare systems move toward digital surgery ecosystems, regulatory-cleared navigation technologies are expected to play a foundational role in modern orthopedic standards of care.
The first U.S. commercial use of the GYDER® Hip Navigation System marks a significant advancement in pin-less, image-less orthopedic surgical guidance. Backed by FDA 510(k) clearance and validated global use, the technology reflects the evolving convergence of precision engineering, regulatory compliance, and outpatient surgical innovation. As adoption expands, real-time navigation platforms like GYDER® may redefine accuracy benchmarks in total hip arthroplasty and accelerate the modernization of orthopedic care.
Source: Gyder Surgical press release
